» Articles » PMID: 12970092

Brief, Repeated, Oxygen-glucose Deprivation Episodes Protect Neurotransmission from a Longer Ischemic Episode in the in Vitro Hippocampus: Role of Adenosine Receptors

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2003 Sep 13
PMID 12970092
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

1. Ischemic preconditioning in the brain consists of reducing the sensitivity of neuronal tissue to further, more severe, ischemic insults. We recorded field epsps (fepsps) extracellularly from hippocampal slices to develop a model of in vitro ischemic preconditioning and to evaluate the role of A1, A2A and A3 adenosine receptors in this phenomenon. 2. The application of an ischemic insult, obtained by glucose and oxygen deprivation for 7 min, produced an irreversible depression of synaptic transmission. Ischemic preconditioning was induced by four ischemic insults (2 min each) separated by 13 min of normoxic conditions. After 30 min, an ischemic insult of 7 min was applied. This protocol substantially protected the tissue from the irreversible depression of synaptic activity. 3. The selective adenosine A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 100 nm), completely prevented the protective effect of preconditioning. The selective adenosine A2A receptor antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385, 100 nm) did not modify the magnitude of fepsp recovery compared to control slices. The selective A3 adenosine receptor antagonists, 3-propyl-6-ethyl-5[ethyl(thio)carbonyl]-2-phenyl-4-propyl-3-pyridinecarboxylate (MRS 1523, 100 nm) significantly improved the recovery of fepsps after 7 min of ischemia. 4. Our results show that in vitro ischemic preconditioning allows CA1 hippocampal neurons to become resistant to prolonged exposure to ischemia. Adenosine, by stimulating A1 receptors, plays a crucial role in eliciting the cell mechanisms underlying preconditioning; A2A receptors are not involved in this phenomenon, whereas A3 receptor activation is harmful to ischemic preconditioning.

Citing Articles

Neuroprotection and Neuroregeneration Strategies Using the rNAION Model: Theory, Histology, Problems, Results and Analytical Approaches.

Bernstein S, Guo Y, Mehrabian Z, Miller N Int J Mol Sci. 2022; 23(24).

PMID: 36555246 PMC: 9778957. DOI: 10.3390/ijms232415604.


miRNA-132/212 Gene-Deletion Aggravates the Effect of Oxygen-Glucose Deprivation on Synaptic Functions in the Female Mouse Hippocampus.

Bormann D, Stojanovic T, Cicvaric A, Schuld G, Cabatic M, Jan Ankersmit H Cells. 2021; 10(7).

PMID: 34359879 PMC: 8306255. DOI: 10.3390/cells10071709.


Activation of Adenosine A Receptor in Ischemic Stroke: Neuroprotection by Tetrahydroxy Stilbene Glycoside as an Agonist.

Ruan L, Li G, Zhao W, Meng H, Zheng Q, Wang J Antioxidants (Basel). 2021; 10(7).

PMID: 34356346 PMC: 8301086. DOI: 10.3390/antiox10071112.


The Current Role of Dexmedetomidine as Neuroprotective Agent: An Updated Review.

Liaquat Z, Xu X, Zilundu P, Fu R, Zhou L Brain Sci. 2021; 11(7).

PMID: 34202110 PMC: 8301952. DOI: 10.3390/brainsci11070846.


G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential.

Vahidinia Z, Joghataei M, Beyer C, Karimian M, Azami Tameh A Mol Neurobiol. 2021; 58(9):4588-4614.

PMID: 34120294 DOI: 10.1007/s12035-021-02435-5.


References
1.
Pringle A, Thomas S, Signorelli F, Iannotti F . Ischaemic pre-conditioning in organotypic hippocampal slice cultures is inversely correlated to the induction of the 72 kDa heat shock protein (HSP72). Brain Res. 1999; 845(2):152-64. DOI: 10.1016/s0006-8993(99)01916-2. View

2.
Murry C, Jennings R, Reimer K . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124-36. DOI: 10.1161/01.cir.74.5.1124. View

3.
Latini S, Bordoni F, Corradetti R, Pepeu G, Pedata F . Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol. 1999; 128(5):1035-44. PMC: 1571729. DOI: 10.1038/sj.bjp.0702888. View

4.
Abbracchio M, Cattabeni F . Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Ann N Y Acad Sci. 2000; 890:79-92. DOI: 10.1111/j.1749-6632.1999.tb07983.x. View

5.
Plaschke K, Weigand M, Michel A, Martin E, Bardenheuer H . Permanent cerebral hypoperfusion: 'preconditioning-like' effects on rat energy metabolism towards acute systemic hypotension. Brain Res. 2000; 858(2):363-70. DOI: 10.1016/s0006-8993(00)01950-8. View